FormWeb • amLODIPine-olmesartan

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

amLODIPine-olmesartan

amLODIPine-olmesartan

Non-formulary ARB Combination Products Formulary
Therapeutic Interchange

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Azor	TABLET, ORAL	5 mg-20 mg, 5 mg-40 mg
Azor	TABLET, ORAL	10 mg-20 mg, 10 mg-40 mg

VIEW MORE Dihydropyridines, Angiotensin II Receptor Antagonists

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

amLODIPine-olmesartan (Azor)

5 mg-20 mg tablet oral Daily
10 mg-20 mg tablet oral Daily

amLODIPine (Norvasc) AND losartan (Cozaar)

ONE 5 mg amLODIPine PLUS ONE 100 mg losartan po Daily
ONE 10 mg amLODIPine PLUS ONE 100 mg losartan po Daily

amLODIPine-olmesartan (Azor)

5 mg-40 mg tablet oral Daily
10 mg-40 mg tablet oral Daily

amLODIPine (Norvasc) AND valsartan (Diovan)

ONE 5 mg amLODIPine PLUS ONE 320 mg valsartan po Daily
ONE 10 mg amLODIPine PLUS ONE 320 mg valsartan po daily

Reviewed: April 27, 2010

Last updated: Mar. 21, 2026

Black Box Warning: Fetal Toxicity

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.